|
1
|
Jia X, Zhu X, Chen S, Wang Y, Liu J, Liu T, Dong Y. Systematic Exploration of the Potential Material Basis and Molecular Mechanism of the Mongolian Medicine Shudage-4 in Attenuating Stress-Induced Gastric Ulcer in Rat. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE : ECAM 2023; 2023:8998368. [PMID: 37362100 PMCID: PMC10289874 DOI: 10.1155/2023/8998368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Revised: 05/31/2023] [Accepted: 06/02/2023] [Indexed: 06/28/2023]
Abstract
Shudage-4, an ancient and well-known formula in traditional Mongolian medicine comprising four different types of traditional Chinese medicine, is widely used in the treatment of gastric ulcers. However, the potential material basis and molecular mechanism of Shudage-4 in attenuating stress-induced gastric ulcers remain unclear. This study aimed to first explore the potential material basis and molecular mechanism of Shudage-4 in attenuating gastric ulcers in rats. The chemical constituents and transitional components in the blood of Shudage-4 were identified by ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS). The rat gastric ulcer model was induced by water immersion restraint stress (WIRS). The ulcer damage to gastric tissue was measured at the gross anatomical level and pathological level by hematoxylin-eosin (HE) staining of gastric tissue. RNA sequencing of gastric tissue and plasma metabolomics were performed to analyze the mechanism of Shudage-4 against gastric ulcers. A Pearson correlation analysis was performed to explore the association between serum metabolites and gene expression of gastric tissue. A total of 30 chemical constituents were identified in Shudage-4 by UPLC-TOF-MS. Among 30 constituents, 13 transitional components in the blood were considered as the potential material basis. Shudage-4 treatment had a significant effect on WIRS-induced gastric ulcers in rats. HE staining of gastric tissue illustrated that WIRS-induced ulcer damage was suppressed by Shudage-4 treatment. RNA sequencing of gastric tissue showed that 282 reversed expression genes in gastric tissue were related to Shudage-4 treatment, and gene set enrichment analysis revealed that Shudage-4 treatment significantly inhibited gene set expression related to reactive oxygen species (ROS), which was also validated by detecting rat gastric tissue MDA, GSH, SOD, GSH-Px, and CAT activities. The plasma metabolomic data demonstrated that 23 significantly differential metabolites were closely associated with the Shudage-4 treatment. The further multiomics joint analysis found that significantly upregulated 5 plasma metabolites in Shudage-4-treated rats compared to model rats were negatively correlated with gene set expression related to ROS in gastric tissue. Shudage-4 alleviated WIRS-induced gastric ulcers by inhibiting ROS generation, which was achieved by regulating plasma metabolites level.
Collapse
Affiliation(s)
- Xin Jia
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
- Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, China
- Engineering Technology Research Center of Pharmacodynamic Substance and Quality Control of Mongolian Medicine in Inner Mongolia, Hohhot 010110, China
| | - Xiaoling Zhu
- Engineering Technology Research Center of Pharmacodynamic Substance and Quality Control of Mongolian Medicine in Inner Mongolia, Hohhot 010110, China
- Inner Mongolian International Mongolian Hospital, Wulanchabudong Street, Hohhot 010090, China
| | - Siyuan Chen
- Department of Natural Medicinal Chemistry, College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China
| | - Yuexuan Wang
- Department of Natural Medicinal Chemistry, College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China
| | - Jing Liu
- Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, China
| | - Tianlong Liu
- Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010059, China
- Key Laboratory of Clinical and Basic Research on Cardiovascular Diseases, Basic Research Team of Cardiovascular Diseases, Inner Mongolia Medical University, Hohhot 010110, China
| | - Yu Dong
- School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
- Engineering Technology Research Center of Pharmacodynamic Substance and Quality Control of Mongolian Medicine in Inner Mongolia, Hohhot 010110, China
- Department of Natural Medicinal Chemistry, College of Pharmacy, Inner Mongolia Medical University, Hohhot 010110, China
| |
Collapse
|
|
2
|
Hübner AA, Sarruf FD, Oliveira CA, Neto AV, Fischer DCH, Kato ETM, Lourenço FR, Baby AR, Bacchi EM. Safety and Photoprotective Efficacy of a Sunscreen System Based on Grape Pomace ( Vitis vinifera L.) Phenolics from Winemaking. Pharmaceutics 2020; 12:E1148. [PMID: 33260841 PMCID: PMC7761385 DOI: 10.3390/pharmaceutics12121148] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2020] [Revised: 11/19/2020] [Accepted: 11/22/2020] [Indexed: 01/12/2023] Open
Abstract
In winemaking, a large amount of grape pomace is produced that is rich in polyphenolics and highly beneficial for human health, as phenols are useful for skin ultraviolet (UV) protection. In this investigation, we evaluated the safety and clinical efficacy of a sunscreen system containing a grape pomace extract from Vitis vinifera L. as a bioactive ingredient. The recovery of phenolics in the waste was performed by percolation. Nine emulsions were developed using a factorial design and two were evaluated clinically: Formulation E, containing only UV filters (butylmethoxydibenzoyl methane, ethylhexyl methoxycinnamate and ethylhexyl dimethyl PABA), and F, with the extract at 10.0% w/w + UV filters. The antioxidant activity was determined by the DPPH assay and the in vitro efficacy was established by sun protection factor (SPF) measurements (Labsphere UV-2000S). Clinical tests were performed to determine safety (human repeated insult patch test) and to confirm efficacy (photoprotective effectiveness in participants). The results showed a synergistic effect between the sunscreen system and the extract on UVB protection and antioxidant activity. Both samples were considered safe. Formulation F was 20.59% more efficient in protecting skin against UVB radiation, taking approximately 21% more time to induce erythema compared to the extract-free sample.
Collapse
Affiliation(s)
- Alexandra A. Hübner
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - Fernanda D. Sarruf
- IPclin—Institute of Integrated Clinical Research, Jundiai 13200-000, Brazil;
| | - Camila A. Oliveira
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - Alberto V. Neto
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - Dominique C. H. Fischer
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - Edna T. M. Kato
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - Felipe R. Lourenço
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - André Rolim Baby
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| | - Elfriede M. Bacchi
- School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil; (A.A.H.); (C.A.O.); (A.V.N.); (D.C.H.F.); (E.T.M.K.); (F.R.L.); (E.M.B.)
| |
Collapse
|
|
3
|
Minciullo PL, Calapai G, Miroddi M, Mannucci C, Chinou I, Gangemi S, Schmidt RJ. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products - part 4: Solidago virgaurea-Vitis vinifera. Contact Dermatitis 2017; 77:67-87. [PMID: 28543097 DOI: 10.1111/cod.12807] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2017] [Revised: 03/05/2017] [Accepted: 03/07/2017] [Indexed: 11/26/2022]
Abstract
This review focuses on contact dermatitis as an adverse effect of a selection of topically used herbal medicinal products for which the European Medicines Agency has completed an evaluation up to the end of November 2013 and for which a Community herbal monograph - now (since 2014) called a 'European Union herbal monograph' - has been produced. The present part 4 addresses species from Solidago virgaurea L. to Vitis vinifera L.
Collapse
Affiliation(s)
- Paola L Minciullo
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125, Messina, Italy.,Operative Unit of Allergy and Clinical Immunology, Azienda Ospedaliera Universitaria Policlinico 'G. Martino', Via Consolare Valeria, 98125, Messina, Italy
| | - Gioacchino Calapai
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125, Messina, Italy
| | - Marco Miroddi
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125, Messina, Italy
| | - Carmen Mannucci
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125, Messina, Italy
| | - Ioanna Chinou
- Division of Pharmacognosy & Chemistry of Natural Products, Department of Pharmacy, University of Athens, 157 71, Zografou, Athens, Greece
| | - Sebastiano Gangemi
- Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria, 98125, Messina, Italy.,Operative Unit of Allergy and Clinical Immunology, Azienda Ospedaliera Universitaria Policlinico 'G. Martino', Via Consolare Valeria, 98125, Messina, Italy.,Institute of Clinical Physiology, IFC CNR, Messina Unit, Via Consolare Valeria, 98125, Messina, Italy
| | | |
Collapse
|
|
4
|
Fiume MM, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Shank RC, Slaga TJ, Snyder PW, Andersen FA. Safety assessment of Vitis vinifera (grape)-derived ingredients as used in cosmetics. Int J Toxicol 2015; 33:48S-83S. [PMID: 25297908 DOI: 10.1177/1091581814545247] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The Cosmetic Ingredient Review Expert Panel (Panel) assessed the safety of 24 Vitis vinifera (grape)-derived ingredients and found them safe in the present practices of use and concentration in cosmetics. These ingredients function in cosmetics mostly as skin-conditioning agents, but some function as antioxidants, flavoring agents, and/or colorants. The Panel reviewed the available animal and clinical data to determine the safety of these ingredients. Additionally, some constituents of grapes have been assessed previously for safety as cosmetic ingredients by the Panel, and others are compounds that have been discussed in previous Panel safety assessments.
Collapse
Affiliation(s)
- Monice M Fiume
- Cosmetic Ingredient Review Senior Scientific Analyst/Writer, Washington, DC, USA
| | - Wilma F Bergfeld
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - Donald V Belsito
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - Ronald A Hill
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | | | - Daniel C Liebler
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - James G Marks
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - Ronald C Shank
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - Thomas J Slaga
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - Paul W Snyder
- Cosmetic Ingredient Review Expert Panel Member, Washington, DC, USA
| | - F Alan Andersen
- Former Director, Cosmetic Ingredient Review, Washington, DC, USA
| |
Collapse
|
|
5
|
Affiliation(s)
- F Giannoccaro
- Cattedra di Allergologia ed Immunologia Clinica Policlinico - piazza G. Cesare, Bari, Italy
| | | | | | | | | | | |
Collapse
|